Ann: Strategy Briefing Day, page-56

First 56 Last

Share
Profile

Follow
clivemax

3,409 Posts.

416

09/11/19

19:59

Post #: 41339161
Share

Originally posted by Thesi ↑

I'd say that would have been happy with their business dealings with Galaxy, they doubled the resource size not long after and discovered that it would have a 50 year life rather than the initial 20.

There is a big difference between conventional lithium production from brine and the POSLX process, in that of the recovery being more efficient and effective. So perhaps this is something that has helped them to increase their production life

A40 wise, maybe there was not the 11 or so offers that the Administrators represented. Or maybe there were but they were just not in the game so a resolution is not far off. But with that said, what if POSCO was interested and wanted to partner with Galaxy there also.

There would be no need to wait and see if Pilbara will be able to build stage 2.

In the 2019 Q2 release it said:

POSCO is currently discussing LOIs for long-term sales with multiple customers, and some of them have been signed up, as the company is able to supply 65,000 tons of lithium annually in the next few years.

and at this stage they only have 1 plant that will be producing 1000tpa.

Waiting on Pilbara is risky as they haven't done what they said they were going to do. This is something I am sure these guys at POSCO will have also observed and might be feeling a little uncertain as to if Pilbara can ever deliver.

Expand

I wonder if this situation with POSCO and Galaxy would be worth a converter somewhere in there!?

GXY Price at posting: $1.10 Sentiment: Buy Disclosure: Held
11 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

OJC

SPC to merge with Original Juice Co and Nature One Dairy

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 158 more messages in this thread...

First 56 Last

Add GXY (ASX) to my watchlist

Ann: Strategy Briefing Day, page-56

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

SPC to merge with Original Juice Co and Nature One Dairy

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News